According to the lawsuits, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:
- Emergent’s Baltimore facility had a history of manufacturing issues increasing the likelihood for massive contaminations;
- The Baltimore facility had received a series of FDA citations as a result of these contamination risks and quality control issues;
- Emergent had been forced to discard millions of doses of COVID-19 vaccines after workers at the facility deviated from manufacturing standards; and
- As a result of the foregoing, the defendants’ public statements about Emergent’s ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore facility were materially false and/or misleading and/or lacked a reasonable basis.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.
